Literature DB >> 8011253

Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study.

G J Harris1, G D Pearlson, J C McArthur, S Zeger, N D LaFrance.   

Abstract

OBJECTIVE: To quantitatively demonstrate the pattern of cerebral perfusion abnormalities in HIV-1-infected individuals described as 'patchiness' or inhomogeneity in previous qualitative emission tomographic imaging studies.
DESIGN: We aimed to create a quantitative measure of inhomogeneity in HIV-infected individuals. High-frequency variance in cortical profiles is an indication of inhomogeneity in the distribution of radiotracer in the cerebral cortex. Therefore, the study analysis was designed to enable the estimation of variance frequencies in cortical profiles.
METHODS: Regional cerebral blood flow was examined in nine mildly demented and 10 cognitively normal HIV-1-seropositive individuals and eight seronegative normal controls using single photon emission computed tomography with the radiotracer [I-123]-N-isopropyl-p-iodoamphetamine. Quantitative analysis was performed using circumferential profiles of cerebral cortical perfusion. Fourier transform power spectra of the profiles were examined as an index of patchiness in tracer distribution.
RESULTS: Normal controls were characterized by strong middle frequency and weak high-frequency power. Both HIV-1-infected groups showed a significant power shift from middle to high frequencies.
CONCLUSIONS: Increased high-frequency variations in both HIV-1-infected groups indicates diffuse cortical perfusion changes compared with normal controls. This study suggests that there are cerebral bloodflow abnormalities in HIV-1-infected individuals both with and without clinically severe dementia.

Entities:  

Mesh:

Year:  1994        PMID: 8011253     DOI: 10.1097/00002030-199404000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder.

Authors:  Thomas Ernst; Caroline S Jiang; Helenna Nakama; Steven Buchthal; Linda Chang
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

Review 2.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 3.  HIV-related neurocognitive impairment in the HAART era.

Authors:  Jessica Robinson-Papp; Kathryn J Elliott; David M Simpson
Journal:  Curr HIV/AIDS Rep       Date:  2009-08       Impact factor: 5.071

4.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

Review 5.  Seeing Is Believing: Nuclear Imaging of HIV Persistence.

Authors:  Timothy J Henrich; Priscilla Y Hsue; Henry VanBrocklin
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

6.  Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.

Authors:  Joanna Bladowska; Brygida Knysz; Anna Zimny; Krzysztof Małyszczak; Anna Kołtowska; Paweł Szewczyk; Jacek Gąsiorowski; Michał Furdal; Marek J Sąsiadek
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.